#us-markets
Aurobindo Pharma: Strong dose of growth opportunities
Aurobindo’s near-term growth driven by US/Lannett, Europe, and Pen-G, with long-term upside from biologics/biosimilars and margin-led expansion.
US markets hold steady amid geopolitical uncertainty as earnings season takes centre stage
US markets are driven by strong corporate earnings and a stable labor market, defying global geopolitical tensions. While investors hope for negotiation, unpredictable political rhetoric and potential oil price spikes pose risks, especially for emerging marke…